ERBB2 and ovarian carcinoma: HER2 is an ideal molecular target for cancer, highly expressed in a variety of cancer cells, such as colorectal cancer, ovarian cancer, prostate cancer, bladder cancer, and lung cancer, especially gastric and esophageal cancer (3–6).